Implications of the 2026 Dyslipidemia Guidelines, Mechanical Thrombectomy in Ischemic Stroke, Safe Sleep Video Intervention via Text Messaging to Low-Income Families, and more
Summary
Hosted by JAMA Deputy Editors Linda Brubaker and Preeti Malani, this episode reviews the 2026 ACC/AHA dyslipidemia guidelines, noting expanded statin eligibility and persistent treatment gaps. They discuss the DISCOUNT trial, which found no benefit and increased harm from thrombectomy for medium or distal artery strokes. The episode also covers a failed text-based intervention for infant safe sleep, a perspective on integrating AI into clinical decision support, and clinical pearls on gastroparesis, male hypogonadism, and ulcerative colitis.
Topics discussed
Introduction and overview of today's topics
New 2026 dyslipidemia guidelines expand statin eligibility
Shifts in cardiovascular risk assessment with PREVENT equations
Treatment gaps and LDL cholesterol goals in US adults
Thrombectomy trial for medium/distal artery stroke occlusion
Text-based video intervention for infant safe sleep practices
Integrating generative AI into clinical decision support
Healthy Dialogue clip: History of science funding
Clinical pearls: Dyslipidemia and ulcerative colitis guidelines
Review on gastroparesis diagnosis and treatment
Patient pages: Male hypogonadism and cyclosporiasis
Conclusion and credits
Listen ad-free on Castria